Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis
Year: 2021
Type: article
Author: †
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, SGLT2 inhibitors, GLP-1 receptor agonists, insulin analogues, drug pricing, target price, cost-effectiveness, low- and middle-income countries, WHO Model List of Essential Medicines, sulfonylureas, insulin glargine, cardiovascular complications, heart failure, end-stage renal disease, microsimulation, access to medicines
Open Access status: green
OpenAlex ID: W3197074662
